These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 190074)

  • 21. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise.
    Wahren J; Sato Y; Ostman J; Hagenfeldt L; Felig P
    J Clin Invest; 1984 May; 73(5):1367-76. PubMed ID: 6715541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for an intrahepatic contribution to the waning effect of glucagon on glucose production in the conscious dog.
    Cherrington AD; Diamond MP; Green DR; Williams PE
    Diabetes; 1982 Oct; 31(10):917-22. PubMed ID: 6759225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
    Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus.
    Wahren J; Felig P; Cerasi E; Luft R
    J Clin Invest; 1972 Jul; 51(7):1870-8. PubMed ID: 5032528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of glucagon to support postabsorptive glucose flux and glycemia in healthy rats and its attenuation in male Zucker diabetic fatty rats.
    Estes SK; Shiota C; O'Brien TP; Printz RL; Shiota M
    Am J Physiol Endocrinol Metab; 2024 Mar; 326(3):E308-E325. PubMed ID: 38265288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of verapamil on basal and glucagon-dependent splanchnic glucose metabolism and insulin secretion in man.
    Gasić S; Bratusch-Marrain P; Waldhäusl W; Korn A
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):36-40. PubMed ID: 3042640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pharmacologic hyperglucagonemia on plasma amino acid concentrations in normal and diabetic man.
    Liljenquist JE; Lewis SB; Cherrington AD; Sinclair-Smith BC; Lacy WW
    Metabolism; 1981 Dec; 30(12):1195-9. PubMed ID: 7031418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus.
    Wahren J; Hagenfeldt L; Felig P
    J Clin Invest; 1975 Jun; 55(6):1303-14. PubMed ID: 1133176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intermittent physiologic hyperglucagonemia on postprandial plasma glucose levels in normal man.
    Mackes K; Rizza R; Gerich J
    Metabolism; 1981 Nov; 30(11):1041-4. PubMed ID: 7026969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
    Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
    J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia.
    Meek TH; Dorfman MD; Matsen ME; Fischer JD; Cubelo A; Kumar MR; Taborsky GJ; Morton GJ
    Diabetes; 2015 Jul; 64(7):2376-87. PubMed ID: 25633417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evanescent effects of hypo- and hyperglucagonemia on blood glucose homeostasis.
    Sherwin R; Wahren J; Felig P
    Metabolism; 1976 Nov; 25(11 Suppl 1):1381-3. PubMed ID: 979638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theophylline potentiates glucagon-induced hepatic glucose production in man but does not prevent hepatic downregulation to glucagon.
    Rizza RA; Haymond MW; Gerich JE
    Metabolism; 1982 Mar; 31(3):205-8. PubMed ID: 7078408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of alanine on glucagon secretion.
    Müller WA; Faloona GR; Unger RH
    J Clin Invest; 1971 Oct; 50(10):2215-8. PubMed ID: 5116210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.